As with its predecessor, the new drug candidate, Jun13296, targets a different viral protein than Paxlovid does and works ...
More than five years since COVID was declared a pandemic, we're still facing the regular emergence of new variants of the ...
The latest variant on the rise is LP.8.1. It’s increasing in Australia, making up close to one in five COVID cases in New ...
COVID-19 as a whole is still a major national and international health concern. So far this year, there have been close to 45 ...
Researchers at Umeå University have discovered that the SARS-CoV-2 variant omicron has developed a stronger binding to human ...
Although the bivalent COVID-19 vaccine conferred moderate protection against symptomatic disease, hybrid immunity provided the strongest protection.
As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...